Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	38.52	67.00	48.37
Graham Fair Price	-43.43	13.38	23.66
PEG	532.40	0.27	0.04
Price/Book	-16.17	3.09	3.68
Price/Cash Flow	380.60	160.51	33.40
Prices/Earnings	123.28	-35.79	16.03
Price/Sales	-11.39	1.61	1.82
Price/FCF	380.60	160.51	33.40
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-13.58	0.08	0.09
Operating Margin	-68.89	0.01	0.03
ROA	-64.88	< 0.005	0.01
ROE	0.06	-0.02	-62.45
ROIC	0.03	< 0.005	-89.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.01	-0.03	-60.49
Dividends QOQ	-0.01	< 0.005	61.90
EBIT QOQ	1.70	-0.73	-57.05
EPS QOQ	3.80	-1.34	-64.69
FCF QOQ	2.26	-0.84	-62.88
Revenue QOQ	0.14	-0.13	-6.63
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	18.24	20.91	14.66
Days Sales Outstanding (DSO)	4.00	6.22	55.78
Inventory Turnover	4.93	4.30	-12.78
Debt/Capitalization	0.49	0.53	6.21
Quick Ratio	0.12	0.15	29.87
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	20.81	19.21	-7.69
Cash	0.57	0.53	-5.97
Capex	-1.20	-1.32	-9.84
Free Cash Flow	2.29	0.37	-83.90
Revenue	42.14	36.80	-12.66
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.58	0.63	7.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.30	31.11	61.23
Naive Interpretation	Member

06 - Financial Health · Bad

Rating